Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Hepatology (Baltimore, Md.)
|
February 5, 2002
Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway
Hirofumi Kawanaka, Michael K Jones, Imre L Szabo, et al.
Antioxidants & Redox Signaling
|
July 31, 2020
Heme Causes Pain in Sickle Mice <i>via</i> Toll-Like Receptor 4-Mediated Reactive Oxygen Species- and Endoplasmic Reticulum Stress-Induced Glial Activation
Jianxun Lei, Jinny Paul, Ying Wang, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
Andrew Kent, Kellen B Gil, Michael K Jones, et al.
American Journal of Hematology
|
February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia
Michael K Jones, Jesse Sanchez, Megan Connor, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Hepatology (Baltimore, Md.)
|
February 5, 2002
Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway
Hirofumi Kawanaka, Michael K Jones, Imre L Szabo, et al.
Antioxidants & Redox Signaling
|
July 31, 2020
Heme Causes Pain in Sickle Mice <i>via</i> Toll-Like Receptor 4-Mediated Reactive Oxygen Species- and Endoplasmic Reticulum Stress-Induced Glial Activation
Jianxun Lei, Jinny Paul, Ying Wang, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
Andrew Kent, Kellen B Gil, Michael K Jones, et al.
American Journal of Hematology
|
February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia
Michael K Jones, Jesse Sanchez, Megan Connor, et al.
Page
of 5